Accenture (ACN) Stock Analysis 2026: Down 38% From Highs With a 65% Screener Margin of Safety at a Decade-Low P/E
April 19, 2026 · Stock Analysis · 10 min read
Accenture (ACN) Stock Analysis 2026: Down 38% From Highs With a 65% Screener Margin of Safety at a Decade-Low P/E
Accenture sits at $194.00 — 38.8% below its 52-week high of $317.43 — while simultaneously reporting 8.3% revenue growth and generating $72.1 billion in trailing twelve-month revenue. That gap between stock price and business performance is the central question in any ACN analysis.
The Equity Rank screener flags ACN with a 64.6% margin of safety and an Overall Score of 75.9 — among the highest readings for any large-cap in the Technology sector. This analysis walks through what the model is seeing, where it may be wrong, and what the bear case means for the thesis.
Accenture at a Glance (April 2026)
| Metric | Value |
|---|---|
| Price | $194.00 |
| 52-Week Range | $177.50 — $317.43 |
| Market Cap | $121.6B |
| Sector | Technology (IT Services) |
| PE TTM | 15.9x |
| Forward PE | 14.2x |
| P/B | 3.82x |
| P/S TTM | 1.69x |
| EV/EBITDA | 9.75x |
| PEG Ratio | 1.50 |
| Revenue TTM | $72.1B |
| Revenue Growth (YoY) | +8.3% |
| Gross Margin | 32.0% |
| Operating Margin | 13.8% |
| Net Margin | 10.6% |
| EPS TTM | $12.43 |
| Forward EPS (est.) | $13.66 |
| EPS Growth (quarterly YoY) | +4.0% |
| ROE | 24.8% |
| Book Value/Share | $50.76 |
| Annual Dividend | $6.37 (3.28% yield) |
| Beta | 1.24 |
| 50-Day Moving Avg | $206.02 |
| 200-Day Moving Avg | $246.43 |
| Analyst Target Price | $250.51 |
| Equity Rank Overall Score | 75.9 / 100 |
| Risk Score | 52.8 (Moderate) |
| SAVE Score | 68.1 |
| Screener Margin of Safety | +64.6% |
| Combined MoS | +67.6% |
| Sector Rank | 6th / 40 (88th percentile) |
| AI Displacement Score | 30 / 100 (Low-Medium) |
| Next Earnings | June 18, 2026 |
Data sourced from Equity Rank screener (last updated April 17, 2026) and AlphaVantage.
Why Did ACN Drop 38.8%?
Accenture peaked near $317 in mid-2025. By April 2026, it had fallen to $177 at its 52-week low before recovering slightly to $194. Three fear narratives converged:
1. DOGE and U.S. Federal Spending Cuts. Accenture's U.S. federal government business represents approximately 8% of revenue — roughly $5.5B annually. When the Department of Government Efficiency began canceling IT contracts in early 2025, ACN was one of the visible casualties. The market priced in a worst-case scenario where multi-year government IT programs get terminated.
2. AI Will Automate Consulting. The bear case argues that generative AI reduces demand for headcount-intensive consulting work. If clients can deploy AI agents to do the work of junior consultants, Accenture's labor-based business model faces structural pressure.
3. Macro Uncertainty and Client Budget Freezes. In a high-tariff, high-uncertainty environment, enterprise clients often delay large IT transformation programs. ACN's discretionary consulting revenue is sensitive to the capital expenditure cycle.
These three fears are real and non-trivial. The question is whether they justify a 38% price decline in a company that is still growing at 8.3%.
Why the Screener Surfaces a 65% Margin of Safety
The Equity Rank screener computes a consensus fair value using four methods against Technology sector multiples. Here is the breakdown:
| Method | Sector Multiple | ACN Input | Fair Value | MoS vs. $194 |
|---|---|---|---|---|
| P/E (TTM) | 25.0x | EPS $12.43 | $310.75 | +37.6% |
| P/B | 8.0x | BVPS $50.76 | $406.08 | +52.2% |
| P/S | 6.0x | RPS ~$114.94 | $689.64 | +71.9% |
| EV/EBITDA | 20.0x | EBITDA/share ~$19.90 | $397.95 | +51.2% |
| Graham Number | — | EPS — BV | $119.10 | -62.7% |
| PEG (Lynch) | — | EPS — PEG — growth | $154.38 | -25.7% |
Sector multiples sourced from Equity Rank sector_multiples table. Technology sector weights: PE 35%, P/S 30%, PEG 20%, Graham 15%. Screener consensus uses PE and P/S (normalized) since PEG and Graham aren't in the 4-method screener pass.
The screener's 64.6% MoS is primarily driven by the P/S comparison: Accenture's current P/S of 1.69x versus the Technology sector median of 6.0x. That 3.5x gap reflects the fundamental tension in ACN's classification — Accenture is in the Technology sector, but its economics look more like a services firm than a software company.
The Graham Number ($119.10) and PEG ($154.38) both surface below current price, providing a useful conservative anchor. These methods suggest ACN at $194 is not cheap on traditional earnings-power metrics.
The full platform consensus (PE 35% + P/S 30% + PEG 20% + Graham 15%) produces a blended fair value of approximately $364, implying a 46.8% MoS — still substantial, and more conservative than the screener's 64.6%.
The Business Case for Accenture in 2026
P/E of 15.9x is near decade lows. When Accenture traded at $300–350 in 2023–2024, its PE was 25–32x. The same company — now growing faster ($72.1B vs. $64.9B two years ago) — trades at 15.9x. The multiple compression is entirely sentiment-driven.
ACN is an AI services beneficiary, not a victim. Accenture disclosed $3B+ in generative AI new bookings in FY2025 and has built a dedicated GenAI practice with over 40,000 practitioners. The scenario where AI replaces consulting work is a 10-year thesis at best; in the near term, deploying AI in Fortune 500 enterprises requires Accenture-style integration expertise.
Revenue growth of 8.3% on $72B base. Growing an IT services business at 8.3% at scale is genuinely difficult. This is not a stagnating business.
3.28% dividend yield — best in years. At $317, ACN's yield was under 2%. At $194, the same $6.37/year dividend yields 3.28%. For a company that has raised its dividend every year since 2011, this is an unusually high entry yield.
ROE of 24.8% on a nearly debt-free balance sheet. Accenture carries minimal net debt. A 24.8% ROE without financial leverage is exceptional for a services business.
Sector rank 6th / 40 in Technology (88th percentile). Of 40 Technology sector stocks in the Equity Rank universe, ACN ranks 6th by margin of safety. The screener model views it as one of the most undervalued large-cap technology names.
Bear Case: Where the Thesis Breaks
The P/S comparison may be structurally misleading. Software companies in the Technology sector justifiably trade at 6x P/S because their gross margins are 70-85% and revenue is recurring. Accenture's gross margin is 32% — structurally closer to a staffing firm than a software platform. Comparing ACN's P/S to a software sector median may overstate the discount.
Federal contracts may not recover. If U.S. government IT spending is structurally reduced — not just temporarily deferred — the $5.5B federal segment faces a sustained headwind that isn't reflected in trailing revenue.
Consulting cycles can be long. Enterprise clients who freeze IT transformation budgets may keep them frozen for 12–18 months. The revenue growth slowdown from discretionary deferral could extend longer than the market currently prices.
EPS growth is decelerating. Quarterly EPS growth of +4.0% YoY is meaningful but down from the +15–20% rates ACN posted in 2022–2023. If margin pressure from AI tool investments or compensation inflation compresses margins further, forward EPS could disappoint.
The stock is below both moving averages. ACN trades below its 50-day MA ($206.02) and 200-day MA ($246.43), and the momentum score of 29.8 reflects this negative price trend. This is a value play, not a momentum play — which means the catalyst for re-rating isn't obvious yet.
What Wall Street Says vs. What the Model Says
| Source | Fair Value | Upside vs. $194 |
|---|---|---|
| Analyst Consensus Target | $250.51 | +29.1% |
| Equity Rank Screener (PE + P/S) | ~$548 | +182% |
| Full Model (PE + P/S + PEG + Graham) | ~$364 | +87.6% |
| Graham Number (Conservative Floor) | $119.10 | -38.6% |
Analysts target $250.51, implying 29% upside — which is the most conservative estimate in the table. The screener's $548 consensus is driven by P/S sector comparison and represents the theoretical value if ACN re-rated to Technology sector multiples.
A reasonable middle-ground interpretation: Accenture trading at 20–22x trailing earnings (its historical midpoint) would put fair value at $248–$273, consistent with third-party analyst estimates and representing a differential of roughly 28–41% above the current $194 under those assumptions.
SAVE Score and Risk Profile
- Overall Score: 75.9 — top quartile among all 800 large-cap stocks in the screener
- SAVE Score: 68.1 — reflects solid Safety (low debt), reasonable Alpha, moderate Value, and weak Edge (momentum below 30)
- Risk Score: 52.8 (Moderate) — higher risk than defensive names like MRK (23.4) or IBM (30.1); beta of 1.24 means ACN moves with market sentiment
- AI Displacement Score: 30 (Low-Medium) — the Equity Rank model assigns moderate AI disruption risk to IT services; lower than software engineers but non-trivial
The risk profile is the key differentiator from the defensive large-caps analyzed earlier this earnings season. ACN is a quality business, but it is more cyclically exposed than a pharma or utility.
What to Watch on June 18, 2026
Accenture reports Q3 FY2026 results on June 18, 2026. The key metrics to monitor:
New bookings. Consensus expects $20B+ in new bookings for the quarter. A shortfall signals client budget freezes are widening. Strength in GenAI bookings (currently $3B+ LTM) would validate the AI deployment thesis.
Revenue guidance. Accenture provides explicit guidance ranges. Any reduction in the full-year revenue growth range (currently 5–7%) would be a negative signal.
Operating margin. Watch for compression from AI tool investments and compensation increases. Any degradation below 13.8% would be concerning.
Government commentary. Management will address the federal segment directly. Quantifying the DOGE-related contract cancellations vs. new wins elsewhere is critical for the bear case.
Explore Accenture's Valuation Further
The DCF Calculator lets you model ACN under different revenue growth scenarios — from a conservative 3% CAGR (federal headwinds persist, discretionary spending compressed) to 10%+ (GenAI booking acceleration, government recovery).
The P/E Ratio Calculator lets you explore what ACN is worth at different multiples on trailing EPS of $12.43 — from a distressed-sector 12x to a re-rated quality 25x, to understand the re-rating path.
The Equity Rank screener shows Accenture's full profile alongside all 800 large-cap stocks — Overall Score 75.9, Screener MoS +64.6%, Risk Score 52.8 — updated weekly.
This article is for informational and educational purposes only. It does not constitute financial advice or a recommendation to purchase or sell Accenture plc (ACN) shares or any other security. All scores, margin of safety estimates, and other metrics are model-based outputs subject to estimation uncertainty. The screener's 64.6% margin of safety is driven by a P/S sector comparison that may not fully reflect Accenture's positioning relative to pure-software Technology sector peers. The full model (PE, P/S, PEG, Graham) produces a more conservative estimate of approximately 46.8% margin of safety. U.S. federal government contract risk (DOGE-related cancellations), AI disruption to the consulting headcount model, and macroeconomic discretionary spending freezes are material risk factors that could prevent the thesis from playing out. Past financial performance does not guarantee future results. All investments involve risk, including potential loss of principal. Equity Rank is not a registered investment adviser. Always conduct your own due diligence and consult a qualified financial adviser before making investment decisions.